12 July 2018
UK BASHH M. genitalium guidelines updated to include macrolide resistance testing
Important updates to the UK BASHH M. genitalium management guidelines are taking the issue of antimicrobial resistance (AMR) seriously. The...
21 June 2018
Clinical data demonstrates significantly increased cure rates using Resistance Guided Therapy for treating the STI Superbug M. genitalium
SpeeDx ResistancePlus® MG test supports new STI management guidelines SpeeDx Pty. Ltd. today announced clinical data contained in a new study...
23 April 2018
SpeeDx and Serosep sign UK and Ireland distribution agreement
SpeeDx has announced a distribution agreement with Serosep Ltd, a leading manufacturer and distributor of laboratory diagnostic solutions. This will...
19 April 2018
SpeeDx receives FDA listing for Mycoplasma genitalium product
SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale...
23 March 2018
Updated guidelines for M. genitalium recommend resistance testing
The Australian STI management guidelines have been updated and now suggest when testing for Mycoplasma genitalium that inclusion of macrolide...
23 February 2018
TGA approval for SpeeDx PlexPCR® VHS | HSV-1&2, VZV & TP |
SpeeDx Multiplexed VZV, Herpes, Syphilis Assay is now fully registered as an IVD in the Australian market. The single-well test is...
